Clinical Trials - ELTX

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT05726864A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid TumorsACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-04-142026-112026-11
NCT04853017A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid TumorsCOMPLETEDPHASE12021-10-042024-09-242023-01-26